Advanced search
Publication Cover
Journal of Medical Economics Volume 22, 2019 - Issue 8
Submit an article Journal homepage
6,418
Views
14
CrossRef citations to date
0
Altmetric
Pharmacoeconomic Trends

Incentives and disincentives to drug innovation: evidence from recent literature

Roger Lee MendozaDepartment of Management, College of Business and Economics, California State University–Los Angeles, Los Angeles, CA, USACorrespondence[email protected]
Pages 713-721 | Received 27 Mar 2019, Accepted 26 Apr 2019, Published online: 12 Jun 2019

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Giovanni Tafuri, Andrea Bracco & Jens Grueger. (2022) Access and pricing of medicines for patients with rare diseases in the European Union: an industry perspective. Expert Review of Pharmacoeconomics & Outcomes Research 22:3, pages 381-389.
Read now
Brian Godman, Andrew Hill, Steven Simoens, Gisbert Selke, Iva Selke Krulichová, Carolina Zampirolli Dias, Antony P Martin, Wija Oortwijn, Angela Timoney, Lars L Gustafsson, Luka Voncina, Hye-Young Kwon, Jolanta Gulbinovic, Dzintars Gotham, Janet Wale, Wânia Cristina Da Silva, Tomasz Bochenek, Eleonora Allocati, Amanj Kurdi, Olayinka O. Ogunleye, Johanna C Meyer, Iris Hoxha, Admir Malaj, Christian Hierländer, Robert Sauermann, Wouter Hamelinck, Guenka Petrova, Ott Laius, Irene Langner, John Yfantopoulos, Roberta Joppi, Arianit Jakupi, Ieva Greiciute-Kuprijanov, Patricia Vella Bonanno, Jf (Hans) Piepenbrink, Vincent de Valk, Magdalene Wladysiuk, Vanda Marković-Peković, Ileana Mardare, Jurij Fürst, Dominik Tomek, Mercè Obach Cortadellas, Corinne Zara, Caridad Pontes, Stuart McTaggart, Tracey-Lea Laba, Øyvind Melien, Durhane Wong-Rieger, SeungJin Bae & Ruaraidh Hill. (2021) Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications. Expert Review of Pharmacoeconomics & Outcomes Research 21:4, pages 527-540.
Read now
Roger Lee Mendoza. (2020) Effects of innovation and insurance coverage on price elasticity of demand for prescription drugs: some empirical lessons in pharmacoeconomics. Journal of Medical Economics 23:9, pages 915-922.
Read now
Howard Trachtman. (2020) Emerging drugs for treatment of focal segmental glomerulosclerosis. Expert Opinion on Emerging Drugs 25:3, pages 367-375.
Read now

Articles from other publishers (10)

Wenbo Hu, Zhuofan Li, Danling Chen, Ziyang Zhu, Xiaotao Peng, Yanbing Liu, Dongming Liao & Ke Zhao. (2024) Unlocking the potential of collaborative innovation to narrow the inter-city urban land green use efficiency gap: Empirical study on 19 urban agglomerations in China. Environmental Impact Assessment Review 104, pages 107341.
Crossref
Zhilong Zhou & Di Qi. (2023) Offensive corporate strategy and collaborative innovation. Finance Research Letters 58, pages 104414.
Crossref
Patrícia Véras Marrone, Fabio Rampazzo Mathias, Wanderley Marques Bernardo, Marina Feliciano Orlandini, Maria Carolina Andrade Serafim, Maria Lídia Rebello Pinho Dias Scoton, Juliano Marçal Lopes, Sérgio Luiz Pereira & Eduardo Mario Dias. (2023) Decision Criteria for Partial Nationalization of Pharmaceutical Supply Chain: A Scoping Review. Economies 11:1, pages 25.
Crossref
Oak-Sung Choo, Yun Yeong Lee, Young Sun Kim, Yeon Ju Kim, Dong Ha Lee, Hantai Kim, Jeong Hun Jang & Yun-Hoon Choung. (2022) Effect of statin on age-related hearing loss via drug repurposing. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1869:11, pages 119331.
Crossref
Daniel Tobias Michaeli, Hasan Basri Yagmur, Timur Achmadeev & Thomas Michaeli. (2022) Value drivers of development stage biopharma companies. The European Journal of Health Economics 23:8, pages 1287-1296.
Crossref
Anna Robb, Marc Rohrschneider, Alex Booth, Peggy Carter, Richard Walker & Georgina Andrews. (2022) Enhancing organisational innovation capability – A practice-oriented insight for pharmaceutical companies. Technovation 115, pages 102461.
Crossref
Denis G. Arnold, Louis H. Amato, Jennifer L. Troyer & Oscar Jerome Stewart. (2022) Innovation and misconduct in the pharmaceutical industry. Journal of Business Research 144, pages 1052-1063.
Crossref
Pierluigi Russo, Angelica Carletto, Gergely Németh & Claudia Habl. (2021) Medicine price transparency and confidential managed-entry agreements in Europe: findings from the EURIPID survey. Health Policy 125:9, pages 1140-1145.
Crossref
Daniel Juárez-López & Alejandro Schcolnik-Cabrera. (2021) Drug Repurposing: Considerations to Surpass While Re-directing Old Compounds for New Treatments. Archives of Medical Research 52:3, pages 243-251.
Crossref
Padmashree Gehl Sampath. (2021) Market Shaping and Market Access in the Global Vaccines Market: Approaches for the Future. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.